A study found that rapamycin decreased macrophage secretion of IL-18 and IL-1β by reducing caspase-1 activation, indicating that inhibition of mTOR may be advantageous for patients with inherited autoimmune diseases. This evidence concerns the gene IL18 and autoimmune disease.